Cercar

01/04/2025 Preventing the progression of cirrhosis to decompensation and death
Villanueva, C, Tripathi, D, Bosch, J. Preventing the progression of cirrhosis to decompensation and death. Nature Reviews Gastroenterology & Hepatology. 2025; 22(4)DOI:10.1038/s41575-024-01031-x. PMID:39870944. IF:51.000(Q1/1D).
01/04/2025 Recompensation in Cirrhosis: Biomarkers and Strategies
Ramírez-Quesada, W, Alvarado-Tapias, E, Shalaby, S, Hernández-Gea, V. Recompensation in Cirrhosis: Biomarkers and Strategies. SEMINARS IN LIVER DISEASE. 2025; 45(01)DOI:10.1055/a-2542-9930. PMID:40179966. IF:3.700(Q2/3D).
01/04/2025 Moderate alcohol-associated hepatitis: A real-world multicenter study
Idalsoaga, F, Díaz, LA, Dunn, W, Mehta, H, Muñoz, K, Caldentey, V, Arnold, J, Ayares, G, Mortuza, R, Sarin, SK, Maiwall, R, Zhang, W, Qian, S, Simonetto, D, Singal, AK, Elfeki, MA, Ramirez-Cadiz, C, Malhi, G, Ahmed, A, Homsi, H, Abid, Z, Cabezas, J, Echavarría, V, Poca, M, Soriano, G, Cuyas, B, Cots, MV, Higuera-De La Tijera, MF, Ayala-Valverde, M, Perez, D, Gomez, J, Abraldes, JG, Al-Karaghouli, M, Jalal, PK, Ibrahim, MA, García-Tsao, G, Goyes, D, Skladany, L, Havaj, DJ, Sulejova, K, Selcanova, SA, Rincón, D, Chacko, KR, Restrepo, JC, Yaquich, P, Toro, LG, Shah, V, Arrese, M, Kamath, PS, Bataller, R, Arab, JP. Moderate alcohol-associated hepatitis: A real-world multicenter study. Hepatology Communications. 2025; 9(4)DOI:10.1097/HC9.0000000000000673. PMID:40131003. IF:4.600(Q1/2D).
11/03/2025 Simvastatin and Rifaximin in Decompensated Cirrhosis: A Randomized Clinical Trial
Pose, E, Jiménez, C, Zaccherini, G, Campion, D, Piano, S, Uschner, FE, de Wit, K, Roux, O, Gananandan, K, Laleman, W, Solé, C, Alonso, S, Cuyàs, B, Ariza, X, Juanola, A, Ma, AT, Napoleone, L, Gratacós-Ginès, J, Tonon, M, Pompili, E, Sánchez-Delgado, J, Allegretti, AS, Morales-Ruiz, M, Carol, M, Pérez-Guasch, M, Fabrellas, N, Pich, J, Martell, C, Joyera, M, Domenech, G, Ríos, J, Torres, F, Serra-Burriel, M, Hernáez, R, Solà, E, Graupera, I, Watson, H, Soriano, G, Bañares, R, Mookerjee, RP, Francoz, C, Beuers, U, Trebicka, J, Angeli, P, Alessandria, C, Caraceni, P, Vargas, VM, Abraldes, JG, Kamath, PS, Ginès, P, LIVERHOPE Consortium. Simvastatin and Rifaximin in Decompensated Cirrhosis: A Randomized Clinical Trial. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 2025; 333(10)DOI:10.1001/jama.2024.27441. PMID:39908052. IF:55.000(Q1/1D).
01/03/2025 Basal PD-L1 expression on leukocyte subpopulations in patients with extensive-stage small cell lung cancer treated with first-line atezolizumab plus platinum and etoposide
Beltrans, JS, Guinart-Cuadra, A, Piedras, A, Recios, SM, Mulet, M, Atenza, CZ, Alejandre, J, Joaquíns, AB, Sullivans, IG, Lópezs, JS, Vidal, S, Majems, M. Basal PD-L1 expression on leukocyte subpopulations in patients with extensive-stage small cell lung cancer treated with first-line atezolizumab plus platinum and etoposide. Journal of Thoracic Oncology. 2025; 20(3)DOI:. PMID:. IF:20.800(Q1/1D).
01/03/2025 Faecal calprotectin-based strategy for long-term monitoring of patients with Crohn's disease without or with mild endoscopic postoperative recurrence
Mañosa, M, Oller, B, Garcia-Planella, E, Guardiola, J, Cañete, F, González-Muñoza, C, Camps, B, Calafat, M, Doménech, E. Faecal calprotectin-based strategy for long-term monitoring of patients with Crohn's disease without or with mild endoscopic postoperative recurrence. DIGESTIVE AND LIVER DISEASE. 2025; 57(3)DOI:10.1016/j.dld.2024.11.028. PMID:39730282. IF:3.800(Q2/3D).